Cibus Stock (NASDAQ: CBUS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 64.039K |
Day Range | - - - |
52 Wk Range | 8.900 - 32.710 |
Market Cap | $345.963M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.23% |
Days to Cover | 3.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cibus (NASDAQ: CBUS) through any online brokerage.
Other companies in Cibus’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), Opthea (NASDAQ:OPT) and Nanobiotix (NASDAQ:NBTX).
The latest price target for Cibus (NASDAQ: CBUS) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 25.00 expecting CBUS to rise to within 12 months (a possible 56.25% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cibus (NASDAQ: CBUS) is $16 last updated April 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Cibus.
Cibus’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Cibus.
Cibus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.